Labcorp
741 hedge funds and large institutions have $15.4B invested in Labcorp in 2019 Q2 according to their latest regulatory filings, with 77 funds opening new positions, 239 increasing their positions, 292 reducing their positions, and 70 closing their positions.
73% more call options, than puts
Call options by funds: $70.2M | Put options by funds: $40.6M
14% more funds holding in top 10
Funds holding in top 10: 14 → 16 (+2)
11% more capital invested
Capital invested by funds: $13.9B → $15.4B (+$1.47B)
10% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 70
0% less funds holding
Funds holding: 744 → 741 (-3)
1.98% less ownership
Funds ownership: 107.88% → 105.91% (-2%)
18% less repeat investments, than reductions
Existing positions increased: 239 | Existing positions reduced: 292
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$164M |
| 2 |
MCM
Melvin Capital Management
New York
|
+$126M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$92.9M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$75.4M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$62.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$176M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$69.6M |
| 3 |
BM
Bridger Management
New York
|
-$50.6M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$48.9M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$48.8M |
LH Hedge Fund Activity: Q2 2019 in Review
741 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q2 2019, worth a combined $15.4B — up 11% from $13.9B a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new LH positions and 70 closed out — a net gain of 7 holders — while 239 added to existing stakes and 292 trimmed.
The largest buyer was Nuveen, adding an estimated $164M. The largest seller was BlackRock, cutting an estimated $176M.
- 741 institutional investors held Labcorp (LH) as of Q2 2019, down from 744 in Q1 2019.
- Funds reported $15.4B of Labcorp stock for Q2 2019, up 11% quarter-over-quarter.
- 77 funds opened new Labcorp positions in Q2 2019 and 70 closed out, a net change of +7 holders.
- The largest Labcorp buyer in Q2 2019 was Nuveen, an estimated $164M added.
- The largest Labcorp seller in Q2 2019 was BlackRock, an estimated $176M sold.
Based on aggregated 13F filings for Q2 2019.